MapLight Therapeutics Inc <MPLT.O>: Canaccord Genuity cuts target price to $24 from $43
MPLT•Related News
Chugai licenses anti-dengue antibody AID351 to GSK in exclusive deal
GSK•
Verisk CFO Elizabeth Mann disposes of 400 common shares worth $71,980
VRSK•
Infleqtion lifts Q2 revenue after accounting adjustment shifts timing on two government contracts
INFQ•
Datavault AI to buy CyberCatch for USD 94.5 million in cash
DVLT•
Vessel struck by unknown projectile in Strait of Hormuz, crew casualty reported, UKMTO says
XLE•